Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Sheila Judge Santacroce und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Parents, Clinical Trials as Topic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Leukemia & Lymphoma Society, Children's Oncology Group NCTN Network Group Operations Center Grant.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Increasing representation in clinical trials is a priority for the National Cancer Institute and Children's Oncology Group (COG). Our survey of COG‐affiliated institutions revealed that many sites have insufficient processes and resources to enroll children whose parents use languages other than English (LOE). We describe reported barriers and facilitators to enrolling children in clinical trials when parents use LOE and propose opportunities for improvement. Procedures We sent a 20‐item survey to COG‐affiliated institutions. Five items allowed respondents to expand on replies to questions about (a) local institutional review board (IRB) requirements regarding translation of consent documents, (b) contributors to provider discomfort consenting parents who use LOE, (c) available language services and resources, and (d) barriers to enrolling children whose parents use LOE or offer ideas about approaches to improvements. Two pairs of researchers independently coded free‐text responses and compared results for concordance.
Results
A total of 139 ( N = 230; 60%) institutions returned the survey. Respondents were mainly physician principal investigators ( n = 79/139; 57%) at the United States sites ( n = 118/139; 85%) serving less than 100 newly diagnosed children per year ( n = 99/139, 71%). They described challenges at multiple levels. Proposed approaches to improvements included centralized provision of translated materials and video educational materials in various languages, and collaborating with IRBs on regulatory processes that protect families and facilitate equitable clinical trial access.
Conclusions
Clinical trial consortia, such as COG, face challenges in enrolling representative samples. Further research is required to design and implement multilevel interventions to ensure equitable access for all, regardless of language used, and mitigate disparate research participation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, North Carolina, USA.
- Columbia University Mailman School of Nursing, New York, New York, USA.
- University of Calgary, Calgary, Alberta, Canada.
- Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Melissa P Beauchemin, Jenny Ruiz, Paula Aristizabal, Manuela Orjuela-Grimm, Anurekha G Hall, Justine Kahn, Lena E Winestone
Förderung
- NCI NIH HHS
- Leukemia & Lymphoma Society
- Children's Oncology Group NCTN Network Group Operations Center Grant
- Leukemia and Lymphoma Society
Zitieren
APA
Santacroce, S. J., Beauchemin, M. P., Pelletier, W., Robles, J. M., Ruiz, J., Blazin, L. J., Aristizabal, P., Orjuela-Grimm, M., Hall, A. G., Kahn, J., Kline, C., Seif, A. E., Velez, M. C., & Winestone, L. E. (2024). Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31321
Vancouver
Santacroce SJ, Beauchemin MP, Pelletier W, Robles JM, Ruiz J, Blazin LJ, et al. Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31321
BibTeX
@article{Santacroce2024,
author = {Santacroce, Sheila Judge and Beauchemin, Melissa P and Pelletier, Wendy and Robles, Joanna M and Ruiz, Jenny and Blazin, Lindsay J and Aristizabal, Paula and Orjuela-Grimm, Manuela and Hall, Anurekha G and Kahn, Justine and Kline, Cassie and Seif, Alix E and Velez, Maria C and Winestone, Lena E},
title = {Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31321}
}
EUVIMED